NetworkNewsWire Announces Publication that Discusses the Innovations of Several Pet Health Care Stocks

NEW YORK, NY--(Marketwired - May 4, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring India Globalization Capital, Inc. (NYSE MKT: IGC), an NNW client positioned as a first mover in developing a portfolio of products using cannabis-based "combination therapies" for the treatment of pain and other conditions.

The publication is entitled, "Paws Firmly Planted for Growth in Multibillion-Dollar Pet Health Market." It highlights several companies developing innovative therapies to improve the health and wellness of pets.

To view the full publication visit: https://www.networknewswire.com/paws-firmly-planted-growth-multibillion-dollar-pet-health-market/

"In 2016 alone, U.S. consumers spent over $65 billion on pet-related products. According to a 2013 study published by the U.S. Bureau of Labor Statistics, U.S. households own approximately 218 million pets, and pet-related expenses for the average U.S. household amounts to about 1 percent of their total annual spending. Further, the North American Pet Health Insurance Association reports that pet health insurance premiums hit $774 million in the U.S. in 2015, with 1.6 million pets being insured by the end of that year. Clearly, consumers are interested in the health and wellbeing of their pets, and they're showing it with dollars.

"One pioneering company, India Globalization Capital (IGC) is forging new paths in the medical marijuana market by exploring the potential health applications of cannabis in domesticated animals. IGC is engaged in the development of phytocannabinoid-based treatments to address pain and a variety of medical conditions, including marijuana-based therapies to treat seizures in dogs and cats.

"IGC offers a novel therapy using cannabinoid extracts to treat such seizures in pets. The company has applied for a U.S. patent based on this therapy, which can be administered via various delivery technologies and has indications for mammals, including dogs and cats. This therapy has the potential to be useful in humans, as well. IGC anticipates conducting metabolic profiling and commencing trials."

About IGC

In the United States, the company develops cannabis-based therapies. IGC has assembled a portfolio of patent filings that encompasses the indications of Pain, Seizures, Epilepsy, and Cachexia using phytocannabinoids. The company is based in Bethesda, Maryland. For more information, visit www.igcinc.us.

About NetworkNewsWire

NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and contributing writers, NNW is uniquely positioned to best serve private and public companies who need to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today's market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, visit https://www.NetworkNewsWire.com

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://nnw.fm/Disclaimer

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's SEC filings. These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements.